CT SCAN DIAGNOSIS: A LARGE-SCALE SINGLE BLIND CLINICAL STUDY UTILIZING CT SCAN TO EXPLORE THE EFFECT OF SPOROLIFE IN CHANGING THE BLOOD AND LYMPHATIC CIRCULATION IN HUMAN BODY Confidential Property of Kenrico LTD All rights Reserved 11. Conclusion Kenrico SAP (Sporolife Activated Prescribing) Sheet significantly improve blood and lymphatic circulation in all 20 participants of group I (experimental group) with reduction of up to 6.00% of body fat and curing series symptoms of sleeping problems, fatigue, constipation, incontinence, pain, cramps, and headache. The most significantly, it can also cure chronic stress and lymphedema. Moreover, Kenrico SAP (Sporolife Activated Prescribing) Sheet was very well tolerated as no adverse reaction was observed during the study. On the contrary, 20 participants of group II (experimental group) at Site B demonstrated that composition without Sporolife is ineffective and can cause series of health symptoms from the increase in body fat percentage (increase of 9%), headaches, and fatigue due to blocked blood circulation. The most importantly, composition without Sporolife can cause the development of lymphedema due to blocked lymphatic circulation and swelling in lymphatic nodes with symptoms of bloating, shortness of breath, and abdominal cramps. The current findings validated the mandatory requirement of using Sporolife in the product by the European Authority. A controlled group at Site C demonstrated that placebo effect was non-existent. The body fat reduction of 0.05% is too insignificant. Also, there were no significant changes to the health symptoms during the 4 and 8 weeks of the application.
RkJQdWJsaXNoZXIy NDU4NTU=